|
BUB1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66411329161065E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.71429999999662E-05 |
| Normal-vs-Stage2 |
6.405700E-02 |
| Normal-vs-Stage3 |
3.77559999999999E-05 |
| Normal-vs-Stage4 |
3.680100E-03 |
| Stage1-vs-Stage2 |
4.686400E-01 |
| Stage1-vs-Stage3 |
2.193200E-04 |
| Stage1-vs-Stage4 |
9.643200E-03 |
| Stage2-vs-Stage3 |
1.281640E-01 |
| Stage2-vs-Stage4 |
2.161400E-01 |
| Stage3-vs-Stage4 |
9.758800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.89150028973017E-10 |
| Normal-vs-AfricanAmerican |
3.180300E-04 |
| Normal-vs-Asian |
8.367700E-02 |
| Caucasian-vs-AfricanAmerican |
9.907000E-01 |
| Caucasian-vs-Asian |
1.256430E-01 |
| AfricanAmerican-vs-Asian |
1.458240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.01803068384288E-12 |
| Normal-vs-Female |
1.51658999999471E-05 |
| Male-vs-Female |
1.598140E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.93089999999519E-05 |
| Normal-vs-Extreme_Weight |
1.63900000005324E-06 |
| Normal-vs-Obese |
1.69729999999202E-06 |
| Normal-vs-Extreme_Obese |
1.749600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.438300E-02 |
| Normal_Weight-vs-Obese |
8.238800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.196200E-03 |
| Extreme_Weight-vs-Obese |
2.355600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.879600E-01 |
| Obese-vs-Extreme_Obese |
2.723900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.504500E-03 |
| Normal-vs-Age(41-60Yrs) |
7.10700387429597E-11 |
| Normal-vs-Age(61-80Yrs) |
2.20509999999674E-05 |
| Normal-vs-Age(81-100Yrs) |
1.299970E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.871800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.778500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.175800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.060000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.012210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.822200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.44609996094647E-09 |
| Normal-VS-Type2 PRCC |
7.34340000030365E-07 |
| Normal-VS-KIRP CIMP |
1.679130E-03 |
| Normal-VS-Unclassified PRCC |
4.10510000000697E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.546480E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.543700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.969500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.919800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.020800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.817500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.993100E-04 |
| Normal-vs-N1 |
1.97820000003013E-06 |
| Normal-vs-N2 |
1.131760E-01 |
| N0-vs-N1 |
4.792400E-04 |
| N0-vs-N2 |
1.919010E-01 |
| N1-vs-N2 |
4.600800E-01 |
|
|
